Gate Neurosciences
PrivateLast Round
M&A
May 27, 2025
Total Funding Raised
$58.9M
Company Overview
Gate Neurosciences is a biotechnology company that develops precision medicines to treat central nervous system disorders by enhancing synaptic function and neuroplasticity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Neurosciences Comparables
Compare Gate Neurosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 81% | |
| Delix Therapeutics | 81% | |
| Spinogenix, Inc. | 78% | |
Gate Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 27, 2025 | ||||
| Convertible Debt | Dec 31, 2024 | ||||
| Convertible Debt | Sep 30, 2022 | ||||
| Convertible Debt | Nov 24, 2021 |
Key People
Founding team and executive leadership
Gate Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioCrossroads | Convertible Debt, Seed |
| Luson BioVentures | Convertible Debt, M&A |
| Innoviva | Convertible Debt, M&A |
| Catalio Capital Management | M&A |
| M Capital | M&A |
| PagodaTree Partners | M&A |
| Tenmile | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2025
$62M round led by Innoviva and Catalio Capital Management.
- Dec 31, 2024
$11M round raised, led by Innoviva.
Gate Neurosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gate Neurosciences's valuation, stock price, and market status.